-3.9%
ARM vs MRNA
+342.9%
-346.8%
-62.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -7.0% | +5.2% | -1.7% |
| 7D | +19.8% | -4.2% | +24.0% | +19.9% |
| 30D | -21.8% | +7.0% | -28.8% | -21.8% |
| 3M | -26.5% | +263.4% | -289.9% | -26.7% |
| 6M | -3.9% | +334.3% | -338.2% | -12.8% |
| All | -3.9% | +342.9% | -346.8% | -12.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling